Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Avanos Medical (AVNS) Revenue (2016 - 2026)

Avanos Medical's Revenue history spans 13 years, with the latest figure at $180.9 million for Q4 2025.

  • On a quarterly basis, Revenue rose 0.72% to $180.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $701.2 million, a 1.95% increase, with the full-year FY2025 number at $701.2 million, up 1.95% from a year prior.
  • Revenue hit $180.9 million in Q4 2025 for Avanos Medical, up from $177.8 million in the prior quarter.
  • Over the last five years, Revenue for AVNS hit a ceiling of $197.4 million in Q1 2022 and a floor of $35.8 million in Q4 2021.
  • Historically, Revenue has averaged $168.6 million across 5 years, with a median of $172.8 million in 2022.
  • Biggest five-year swings in Revenue: tumbled 80.65% in 2021 and later skyrocketed 407.26% in 2022.
  • Tracing AVNS's Revenue over 5 years: stood at $35.8 million in 2021, then skyrocketed by 407.26% to $181.6 million in 2022, then fell by 4.57% to $173.3 million in 2023, then increased by 3.64% to $179.6 million in 2024, then rose by 0.72% to $180.9 million in 2025.
  • Business Quant data shows Revenue for AVNS at $180.9 million in Q4 2025, $177.8 million in Q3 2025, and $175.0 million in Q2 2025.